Vitualla, Erlie May R.
HRN: 23-16-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/18/2023
06/25/2023
IV
600mg
Q8H
Open Fracture Type 1, L Radius And Ulna
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes